Exelixis (EXEL) Reiterated at Market Outperform by Citizens After ESMO '25 Meeting

February 11, 2026 5:21 AM EST Send to a Friend
Citizens analyst Silvan Turkcan reiterated a Market Outperform rating and $50.00 price target on Exelixis (NASDAQ: EXEL).The analyst commented, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login